<DOC>
	<DOC>NCT01345799</DOC>
	<brief_summary>In Crohn's Disease Patients - To evaluate the efficacy of TRK-170 - To evaluate the PK characteristics of TRK-170 - To assess the safety of TRK-170</brief_summary>
	<brief_title>A Study of TRK-170 for the Treatment of Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Patient has a diagnosis of Crohn's Disease before screening Patient has stable disease activity Patient has had a clinically significant illness prior to screening Patient with clinically significant deviations in laboratory values</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Crohn's Disease Activity Index</keyword>
	<keyword>Crohn's Disease</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
</DOC>